3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
3
Neoplasm Metastasis
2
Head and Neck Neoplasms
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Tertiary Lymphoid Structures
1
Sarcoma
1
Prostatic Neoplasms
1
Penile Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Metastatic Solid Tumors
1
Mesothelioma, Malignant
1
Mesothelioma
1
Melanoma
1
Hematologic Neoplasms
1
Colonic Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Non-Small-Cell Lung
1
Brain Neoplasms
1
Anus Neoplasms
1
Interventions
Etoposide
7
Cisplatin
7
fludarabine
4
Cyclophosphamide
4
fludarabine phosphate
3
Paclitaxel
3
Carboplatin
3
Bleomycin
3
Automobiles
3
pembrolizumab
2
etoposide phosphate
2
Vorinostat
2
Sirolimus
2
Mesna
2
Ifosfamide
2
Drug Therapy
2
130-nm albumin-bound paclitaxel
2
tremelimumab
1
tozuleristide
1
sodium thiosulfate
1
repotrectinib
1
pralsetinib
1
pegfilgrastim
1
lutetium Lu 177 dotatate
1
durvalumab
1
cabozantinib
1
Watchful Waiting
1
Teniposide
1
Surveys and Questionnaires
1
Stem Cell Transplantation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms, Germ Cell and Embryonal
×
bintrafusp alfa protein, human
×
1 year
×
Clear all
No trials found.